Eli Lilly (LLY)
(Delayed Data from NYSE)
$733.51 USD
+8.64 (1.19%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $733.20 -0.31 (-0.04%) 6:52 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Average Brokerage Rating
Current ABR | 1.20 |
ABR (Last week) | 1.20 |
# of Recs in ABR | 22 |
Average Target Price | $774.48 |
LT Growth Rate | 36.60% |
Industry | Large Cap Pharmaceuticals |
Industry Rank by ABR | 198 of 252 |
Current Quarter EPS Est: | 2.53 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 19 | 19 | 19 | 19 | 19 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/12/2024 | SVB Securities | David Risinger | Strong Buy | Strong Buy |
4/2/2024 | Guggenheim Securities | Seamus Fernandez | Strong Buy | Strong Buy |
4/1/2024 | Cantor Fitzgerald & Co | Louise Chen | Strong Buy | Strong Buy |
3/15/2024 | Truist Securities | Robyn Karnauskas | Strong Buy | Strong Buy |
2/7/2024 | BMO Capital Markets | Evan Seigerman | Strong Buy | Strong Buy |
1/3/2024 | Argus Research Corp. | David A Toung | Strong Buy | Strong Buy |
12/21/2023 | Daiwa America | Narumi Nakagiri | Not Available | Strong Buy |
11/8/2023 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/4/2023 | Berenberg Bank | Kerry Holford | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.